
Product Insights
Olanzapine, marketed by EG Labo, is an oral atypical antipsychotic prescribed for the management of schizophrenia and bipolar disorder. Its strong efficacy in reducing psychotic symptoms and preventing relapse makes it a cornerstone treatment in psychiatry. However, it carries notable risks such as weight gain, metabolic disturbances, sedation, and possible movement disorders, requiring careful monitoring and medical supervision.
Comparative Analysis
Within the psychopharmacology market, olanzapine stands out as a widely used atypical antipsychotic offering broad symptom control, yet its metabolic side-effect profile positions it alongside other high-risk agents such as clozapine and risperidone.
Unlock Full Product Insights
Scan this and millions of other daily products to reveal hidden ingredients, safety alerts, and comprehensive analysis with the free NutrScan app.
Frequently Asked Questions
Everything you need to know about olanzapîne.







